Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China flag China · Delayed Price · Currency is CNY
20.91
-0.21 (-0.99%)
Jul 18, 2025, 3:04 PM CST

SHE:002932 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
4,6364,1035,3418,9457,7614,350
Upgrade
Market Cap Growth
-20.35%-23.18%-40.29%15.26%78.41%80.42%
Upgrade
Enterprise Value
1,6173,7953,3886,1986,6963,786
Upgrade
Last Close Price
21.1217.3521.4833.2527.3515.95
Upgrade
PE Ratio
116.6755.0671.282.135.499.28
Upgrade
PS Ratio
12.9111.727.130.852.744.54
Upgrade
PB Ratio
0.770.680.851.322.723.90
Upgrade
P/TBV Ratio
0.800.710.891.382.804.01
Upgrade
P/FCF Ratio
--18.912.427.5813.13
Upgrade
P/OCF Ratio
--13.612.236.8912.09
Upgrade
EV/Sales Ratio
4.5010.844.520.592.373.95
Upgrade
EV/EBITDA Ratio
--57.131.203.936.74
Upgrade
EV/EBIT Ratio
---1.213.986.95
Upgrade
EV/FCF Ratio
-4.91-11.991.686.5411.43
Upgrade
Debt / Equity Ratio
0.000.000.010.030.020.13
Upgrade
Debt / EBITDA Ratio
--0.640.040.030.25
Upgrade
Debt / FCF Ratio
--0.170.060.040.43
Upgrade
Asset Turnover
0.050.050.091.671.170.93
Upgrade
Inventory Turnover
2.382.061.6014.703.522.68
Upgrade
Quick Ratio
9.374.322.423.104.843.42
Upgrade
Current Ratio
10.224.842.703.255.503.94
Upgrade
Return on Equity (ROE)
-0.08%0.43%1.06%91.05%72.97%54.97%
Upgrade
Return on Assets (ROA)
-1.66%-1.31%-0.05%50.90%43.43%32.96%
Upgrade
Return on Capital (ROIC)
-1.85%-1.48%-0.07%65.03%50.68%36.36%
Upgrade
Return on Capital Employed (ROCE)
---75.20%58.60%48.70%
Upgrade
Earnings Yield
0.84%1.82%1.40%47.05%18.21%10.78%
Upgrade
FCF Yield
-7.10%-6.58%5.29%41.36%13.19%7.62%
Upgrade
Dividend Yield
5.82%7.09%0.56%10.50%7.41%4.04%
Upgrade
Payout Ratio
121.84%63.59%777.41%13.08%20.05%1.80%
Upgrade
Buyback Yield / Dilution
5.54%0.54%1.22%-8.61%-1.43%-0.23%
Upgrade
Total Shareholder Return
11.34%7.63%1.78%1.89%5.98%3.80%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.